Effects of canagliflozin, an SGLT2 inhibitor, on hepatic function in Japanese patients with type 2 diabetes mellitus: pooled and subgroup analyses of clinical trials.
J Gastroenterol
; 53(1): 140-151, 2018 01.
Article
in En
| MEDLINE
| ID: mdl-28669071
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 2
/
Canagliflozin
/
Sodium-Glucose Transporter 2 Inhibitors
/
Hypoglycemic Agents
Type of study:
Clinical_trials
/
Systematic_reviews
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Gastroenterol
Journal subject:
GASTROENTEROLOGIA
Year:
2018
Document type:
Article
Affiliation country:
Country of publication: